Anne Wojcicki, 23andMe CEO (Jordan Vonderhaar/Bloomberg via Getty Images)
February 24, 2025 11:35 AM ESTUpdated 02:08 PM
Financing
Health Tech

23and­Me's CEO sub­mits bid to take com­pa­ny pri­vate for $74.7M

Ngai Yeung

Health Tech Reporter

Anne Wo­j­ci­c­ki, the CEO of 23andMe, has sub­mit­ted a new of­fer to take the com­pa­ny pri­vate with pri­vate eq­ui­ty firm New Moun­tain Cap­i­tal months af­ter …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er hires ex-FDA deputy Pa­trizia Cavaz­zoni as chief med­ical of­fi­cer

Post-Hoc: Phar­ma CEOs' al­ter­na­tive re­al­i­ty with Trump

Pfiz­er wants in on Sum­mit’s goal to beat Keytru­da via ADC com­bos

FDA lifts hold on En­trada's Duchenne drug af­ter two years

Sanofi, Te­va bol­ster case for IBD drug with Phase 2 da­ta, de­spite po­ten­tial com­pe­ti­tion

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times